Corbus Pharmaceuticals Holdings, Inc. / "Corporate Governance" | Tables in SEC filings

CRBP Corbus Pharmaceuticals Holdings, Inc.

Annual report

ITEM		Page
	PART I
1.	Business	4
1A.	Risk Factors	26
1B.	Unresolved Staff Comments	54
1C.	Cybersecurity	54
2.	Properties	54
3.	Legal Proceedings	54
4.	Mine Safety Disclosures	54

	PART II
5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	55
6.	[Reserved]	55
7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	56
7A.	Quantitative and Qualitative Disclosures About Market Risk	63
8.	Financial Statements and Supplementary Data	63
9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	63
9A.	Controls and Procedures	64
9B.	Other Information	65
9C.	Disclosure Regarding Foreign Jurisdiction that Prevents Inspections	65

	PART III
10.	Directors, Executive Officers and Corporate Governance	66
11.	Executive Compensation	71
12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	77
13.	Certain Relationships and Related Transactions, and Director Independence	80
14.	Principal Accountant Fees and Services	81

	PART IV
15.	Exhibits and Financial Statement Schedules	83
16.	Form 10-K Summary	86

Table search / Corbus Pharmaceuticals Holdings, Inc. / "Corporate Governance"